IBDEI11G ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16692,1,4,0)
 ;;=4^Z82.2
 ;;^UTILITY(U,$J,358.3,16692,2)
 ;;=^5063366
 ;;^UTILITY(U,$J,358.3,16693,0)
 ;;=Z84.0^^88^880^41
 ;;^UTILITY(U,$J,358.3,16693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16693,1,3,0)
 ;;=3^Family Hx of Skin Diseases
 ;;^UTILITY(U,$J,358.3,16693,1,4,0)
 ;;=4^Z84.0
 ;;^UTILITY(U,$J,358.3,16693,2)
 ;;=^5063388
 ;;^UTILITY(U,$J,358.3,16694,0)
 ;;=Z82.79^^88^880^18
 ;;^UTILITY(U,$J,358.3,16694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16694,1,3,0)
 ;;=3^Family Hx of Congen Malform,Deformations & Chromsoml Abnlt
 ;;^UTILITY(U,$J,358.3,16694,1,4,0)
 ;;=4^Z82.79
 ;;^UTILITY(U,$J,358.3,16694,2)
 ;;=^5063374
 ;;^UTILITY(U,$J,358.3,16695,0)
 ;;=Z84.89^^88^880^39
 ;;^UTILITY(U,$J,358.3,16695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16695,1,3,0)
 ;;=3^Family Hx of Other Spec Conditions
 ;;^UTILITY(U,$J,358.3,16695,1,4,0)
 ;;=4^Z84.89
 ;;^UTILITY(U,$J,358.3,16695,2)
 ;;=^5063393
 ;;^UTILITY(U,$J,358.3,16696,0)
 ;;=Z81.1^^88^880^12
 ;;^UTILITY(U,$J,358.3,16696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16696,1,3,0)
 ;;=3^Family Hx of Alcohol Abuse/Dependence
 ;;^UTILITY(U,$J,358.3,16696,1,4,0)
 ;;=4^Z81.1
 ;;^UTILITY(U,$J,358.3,16696,2)
 ;;=^5063359
 ;;^UTILITY(U,$J,358.3,16697,0)
 ;;=Z82.62^^88^880^38
 ;;^UTILITY(U,$J,358.3,16697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16697,1,3,0)
 ;;=3^Family Hx of Osteoporosis
 ;;^UTILITY(U,$J,358.3,16697,1,4,0)
 ;;=4^Z82.62
 ;;^UTILITY(U,$J,358.3,16697,2)
 ;;=^5063372
 ;;^UTILITY(U,$J,358.3,16698,0)
 ;;=Z83.71^^88^880^17
 ;;^UTILITY(U,$J,358.3,16698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16698,1,3,0)
 ;;=3^Family Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,16698,1,4,0)
 ;;=4^Z83.71
 ;;^UTILITY(U,$J,358.3,16698,2)
 ;;=^5063386
 ;;^UTILITY(U,$J,358.3,16699,0)
 ;;=Z84.81^^88^880^22
 ;;^UTILITY(U,$J,358.3,16699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16699,1,3,0)
 ;;=3^Family Hx of Genetic Disease
 ;;^UTILITY(U,$J,358.3,16699,1,4,0)
 ;;=4^Z84.81
 ;;^UTILITY(U,$J,358.3,16699,2)
 ;;=^5063392
 ;;^UTILITY(U,$J,358.3,16700,0)
 ;;=Z86.010^^88^880^70
 ;;^UTILITY(U,$J,358.3,16700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16700,1,3,0)
 ;;=3^Personal Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,16700,1,4,0)
 ;;=4^Z86.010
 ;;^UTILITY(U,$J,358.3,16700,2)
 ;;=^5063456
 ;;^UTILITY(U,$J,358.3,16701,0)
 ;;=Z86.14^^88^880^75
 ;;^UTILITY(U,$J,358.3,16701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16701,1,3,0)
 ;;=3^Personal Hx of MRSA Infection
 ;;^UTILITY(U,$J,358.3,16701,1,4,0)
 ;;=4^Z86.14
 ;;^UTILITY(U,$J,358.3,16701,2)
 ;;=^5063464
 ;;^UTILITY(U,$J,358.3,16702,0)
 ;;=Z86.31^^88^880^71
 ;;^UTILITY(U,$J,358.3,16702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16702,1,3,0)
 ;;=3^Personal Hx of Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,16702,1,4,0)
 ;;=4^Z86.31
 ;;^UTILITY(U,$J,358.3,16702,2)
 ;;=^5063467
 ;;^UTILITY(U,$J,358.3,16703,0)
 ;;=Z86.711^^88^880^101
 ;;^UTILITY(U,$J,358.3,16703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16703,1,3,0)
 ;;=3^Personal Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,16703,1,4,0)
 ;;=4^Z86.711
 ;;^UTILITY(U,$J,358.3,16703,2)
 ;;=^5063474
 ;;^UTILITY(U,$J,358.3,16704,0)
 ;;=Z86.72^^88^880^107
 ;;^UTILITY(U,$J,358.3,16704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16704,1,3,0)
 ;;=3^Personal Hx of Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,16704,1,4,0)
 ;;=4^Z86.72
 ;;^UTILITY(U,$J,358.3,16704,2)
 ;;=^5063476
